Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Entinostat in patients with relapsed or refractory abdominal neuroendocrine tumors.
Journal: The oncologist
Published: April 07, 2024
Androgen-targeting therapeutics mitigate the adverse effect of GnRH agonist on the risk of neurodegenerative disease in men treated for prostate cancer.
Journal: Cancer medicine
Published: October 06, 2021
The expanding role of hormones in cancer.
Journal: Endocrine oncology (Bristol, England)
Published: February 04, 2021
Loss of PTEN Accelerates NKX3.1 Degradation to Promote Prostate Cancer Progression.
Journal: Cancer research
Published: December 31, 2018
Development, Evaluation, and Implementation of a Pan-African Cancer Research Network: Men of African Descent and Carcinoma of the Prostate.
Journal: Journal of global oncology
Published: September 28, 2018
Nkx3.1 controls the DNA repair response in the mouse prostate.
Journal: The Prostate
Published: September 21, 2015
Treatment of the Prostate in the Presence of Metastases: Lessons from Other Solid Tumors.
Journal: European urology
Published: May 31, 2015
The Tumor Suppressor NKX3.1 Is Targeted for Degradation by DYRK1B Kinase.
Journal: Molecular cancer research : MCR
Published: December 16, 2014
Variant NKX3.1 and Serum IGF-1: Investigation of Interaction in Prostate Cancer.
Journal: Genes & cancer
Published: May 29, 2013
Last Updated: 09/26/2026